Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis

Journal of the American Society of Nephrology

Volumn 10, Issue 12, 1999, Pages 2585-2590

  Morgera, Stanislao ^a,b   Kuchinke, Simone ^a   Budde, Klemens ^a   Lun, Andreas ^a   Hocher, Berthold ^a   Neumayer, Hans Hellmut ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HUMAN; HYPEROSMOLARITY; MALE; PARACRINE SIGNALING; PLASMA VOLUME; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0032706945     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Dobbie JW: Morphology of the peritoneum in CAPD. Blood Purif 7: 74-85, 1989
2. Di Paolo N, Sacchi G, De Mia M, Gaggiotti E, Capotondo L, Rossi P, Bernini M, Pucci AM, Ibba L, Sabatelli P, Alessandrini C: Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 44: 204-211, 1986
3. Honda K, Nitta K, Yamara S, Nikei W: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72: 171-176, 1996
4. Dobbie JW, Lloyd JK, Gall CA: Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Adv Perit Dial 6: 3-12, 1990
5. Dobbie JW: Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 12: 14-27, 1992
6. Dobbie JW: New concepts in molecular biology and ultrastructural pathology of the peritoneum: Their significance for peritoneal dialysis. Am J Kidney Dis 15: 97-109, 1990
7. Di Paolo N, Sacchi G: Peritoneal vascular changes in continuous ambulatory peritoneal dialysis: An in vivo model for the study of diabetic microangiopathy. Perit Dial Int 9: 41-45, 1989
8. Goto K, Warner TD: Molecular pharmacology: Endothelin versatility. Nature 375: 539-540, 1995
9. Levin ER: Endothelins. N Engl J Med 333: 356-363, 1995
10. Rubanyi GM, Polokoff MA: Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46: 325-415, 1994
11. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT: Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 27: 2130-2134, 1993
12. Vancheeswaran R, Azam A, Black CM, Dashwood MR: Localisation of endothelin-1 and its binding sites in scleroderma skin. J Rheumatol 21: 1268-1276, 1994
13. Knock GA, Terenghi G, Bunker CB, Bull HA, Dowd PM, Polak JM: Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis. J Invest Dermatol 101: 73-78, 1993
14. Abraham DJ, Vancheeswaran R, Dashwood MR, Rajkumar VS, Pantelides P, Shi-wen X, du Bois RM, Black CM: Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma associated fibrotic lung disease. Am J Pathol 151: 831-841, 1997
15. Rochey DC, Chung JJ: Endothelin antagonism in experimental hepatic fibrosis. J Clin Invest 98: 1381-1388, 1996
16. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Neumayer HH, Bauer C, Schleuning WD, Theuring F: Endothelin-1 transgenic mice develop renal cysts, interstitial fibrosis and glomerulosclerosis but not hypertension. J Clin Invest 99: 1380-1389, 1997
17. Hocher B, Liefeldt L, Thöne-Reineke C, Orzekowski HD, Distler A, Bauer C, Paul M: Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 28: 196-201, 1996
18. Sessa WC, Kaw S, Hecker M, Vane JR: The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 174: 613-618, 1991
19. Waters CM, Chang JY, Glucksberg MR, DePaola N, Grotberg JB: Mechanical forces alter growth factor release by pleural mesothelial cells. Am J Physiol 272: L552-L557, 1997
20. Yasuda T, Kondo S, Homma T, Harris RC: Regulation of extracellular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 98: 1991-2000, 1996
21. Kuchan MJ, Frangos JA: Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 264: H150-H156, 1993
22. Hocher B, George I, Rebstock J, Bauch A, Schwarz A, Neumayer HH, Bauer C: Endothelin system-dependent cardiac remodeling in renovascular hypertension. Hypertension 33: 816-822, 1999
23. Twardowski ZJ: PET-A simpler approach to determining prescriptions for adequate dialysis therapy. In: Advances in Peritoneal Dialysis, edited by Khanna R, Toronto, University of Toronto Press, 1990
24. Garred LJ, Canaud B, Farrell PC: A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis. ASAIO J 6: 131-137, 1983
25. Pannekeet MM, Imholz LT, Struijk DG, Koomen GCM, Langedijk MJ, Schouten N, De Waart R, Hiralall J, Krediet RT: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 48: 866-875, 1995
26. Pedersen FB, Ryttov N, Deleuran P, Dragsholt C, Kildeberg P: Acetate versus lactate in peritoneal dialysis solution. Nephron 39: 55-58, 1985
27. Wesson DE, Simoni J, Green DF: Reduced extracellular pH increases endothelin-1 secretion by human renal microvascular endothelial cells. J Clin Invest 101: 578-583, 1998
28. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
29. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco P, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 challenge with albumin and other proteins. Am J Kidney Dis 26: 934-941, 1995
30. Topley N, Brown Z, Jörres A, Westwick J, Davies M, Coles GA, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-1. Am J Pathol 142: 1876-1886, 1993
31. Ehrenreich H, Anderson RW, Fox CH: Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172: 1741-1748, 1990
32. Harty JC, Boulton H, Uttley L, Heelis N, Venning M, Gokal R: Limitations of urea kinetic modeling as predictors of nutritional and dialysis adequacy in CAPD. Am J Nephrol 13: 454-463, 1992
33. CANUSA Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198-207, 1996
34. Harty J, Boulton H, Venning M, Gokal R: Impact of increasing dialysis volume on adequacy targets: A prospective study. J Am Soc Nephrol 8 : 1304-1310, 1997
35. Popovich RP, Pyle WK, Bomar JB, Moncrief JW: Peritoneal dialysis. AIChE Sym Series 75 187: 31-45, 1979
36. Popovich RP, Moncrief JW: Transport kinetics. In: Peritoneal Dialysis, 2nd Ed., edited by Nolph KD, Boston, Niijhoff, 1985, pp 115-137
37. George S, Ryan L, Fritzsch S, Miller R: A clinical study of 2.5 liter exchange volumes. Adv Perit Dial 6: 72-77, 1989
38. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT: Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 43: 1339-1346, 1993
39. Nolph KD, Ghods AJ, Van Stone J, Brown PA: The effects of intraperitoneal vasodilators on peritoneal clearances. ASAIO Trans 22: 586-594, 1976
40. Nolph KD, Ghods AJ, Brown PA, Miller F, Harris P, Pyle K, Popovich R: Effects of nitroprusside on peritoneal mass transfer coefficients and microvascular physiology. ASAIO Trans 23: 210-218, 1977
41. Flessner MF: Osmotic barrier of the parietal peritoneum. Am J Physiol 267: F861-F870, 1994
42. Douma CE, De Waart DR, Struijk DG, Krediet RT: The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 57: 1885-1892, 1997
43. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
44. Hocher B, Thöne-Reineke C, Bauer C, Raschack M, Neumayer HH: The paracrine endothelin system: Pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 35: 175-189, 1997
45. Rizvi MAD, Katwa L, Spadone DP, Myers PR: The effects of endothelin-1 on collagen type I and type II synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol 28: 243-253, 1996
46. Bitterman PB, Rennard SI, Adelberg S, Crystal RG: Role of fibronectin as a growth factor for fibroblasts. J Cell Biol 97: 1925-1932, 1983
47. Peacock AJ, Dawes KE, Schock A, Gray AJ, Reeves JT, Laurent GJ: Endothelin-1 and endothelin-3 include chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 7: 492-499, 1992
48. - production in human alveolar macrophages. Am J Physiol 261: L478-L484, 1991